<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Postepy Dermatol Alergol</journal-id><journal-id journal-id-type="iso-abbrev">Postepy Dermatol Alergol</journal-id><journal-id journal-id-type="publisher-id">PDIA</journal-id><journal-title-group><journal-title>Advances in Dermatology and Allergology/Post&#x00229;py Dermatologii i Alergologii</journal-title></journal-title-group><issn pub-type="ppub">1642-395X</issn><issn pub-type="epub">2299-0046</issn><publisher><publisher-name>Termedia Publishing House</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6640024</article-id><article-id pub-id-type="publisher-id">76425</article-id><article-id pub-id-type="doi">10.5114/ada.2018.76425</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>The effect of fennel essential oil and <italic>trans</italic>-anethole on antibacterial activity of mupirocin against <italic>Staphylococcus aureus</italic> isolated from asymptomatic carriers</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Kwiatkowski</surname><given-names>Pawe&#x00142;</given-names></name><xref ref-type="aff" rid="aff0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Pruss</surname><given-names>Agata</given-names></name><xref ref-type="aff" rid="aff0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Masiuk</surname><given-names>Helena</given-names></name><xref ref-type="aff" rid="aff0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Mnichowska-Polanowska</surname><given-names>Magdalena</given-names></name><xref ref-type="aff" rid="aff0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Kaczmarek</surname><given-names>Maciej</given-names></name><xref ref-type="aff" rid="aff0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Giedrys-Kalemba</surname><given-names>Stefania</given-names></name><xref ref-type="aff" rid="aff0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Do&#x00142;&#x00119;gowska</surname><given-names>Barbara</given-names></name><xref ref-type="aff" rid="aff0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Zieli&#x00144;ska-Bli&#x0017a;niewska</surname><given-names>Hanna</given-names></name><xref ref-type="aff" rid="aff0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Olszewski</surname><given-names>Jurek</given-names></name><xref ref-type="aff" rid="aff0004">4</xref></contrib><contrib contrib-type="author"><name><surname>Sienkiewicz</surname><given-names>Monika</given-names></name><xref ref-type="aff" rid="aff0003">3</xref></contrib></contrib-group><aff id="aff0001"><label>1</label>Department of Microbiology, Immunology and Laboratory Medicine, Pomeranian Medical University, Szczecin, Poland</aff><aff id="aff0002"><label>2</label>Department of Experimental and Clinical Pharmacology, Pomeranian Medical University, Szczecin, Poland</aff><aff id="aff0003"><label>3</label>Department of Allergology and Respiratory Rehabilitation, 2<sup>nd</sup> Chair of Otolaryngology, Medical University of Lodz, Lodz, Poland</aff><aff id="aff0004"><label>4</label>Department of Otolaryngology and Laryngological Oncology, 2<sup>nd</sup> Chair of Otolaryngology, Medical University of Lodz, Lodz, Poland</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Pawe&#x00142; Kwiatkowski MSc Eng, Department of Microbiology, Immunology and Laboratory Medicine, Pomeranian Medical University, 72 Powstancow Wielkopolskich St, 70-111 Szczecin, Poland. phone: +48 91 466 16 52, fax: +48 91 466 16 59. e-mail: <email xlink:href="pawel.kwiatkowski@pum.edu.pl">pawel.kwiatkowski@pum.edu.pl</email></corresp></author-notes><pub-date pub-type="epub"><day>18</day><month>6</month><year>2019</year></pub-date><pub-date pub-type="ppub"><month>6</month><year>2019</year></pub-date><volume>36</volume><issue>3</issue><fpage>308</fpage><lpage>314</lpage><history><date date-type="received"><day>21</day><month>2</month><year>2018</year></date><date date-type="accepted"><day>01</day><month>4</month><year>2018</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2019 Termedia Sp. z o. o.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.</license-p></license></permissions><abstract><sec id="s1"><title>Introduction</title><p><italic>Staphylococcus aureus</italic> constitutes the most pathogenic species within the staphylococcal genus. Humans remain the major reservoirs of this pathogen which colonizes mostly anterior nares of healthy individuals.</p></sec><sec id="s2"><title>Aim</title><p>To investigate the effect of fennel essential oil (FEO) and <italic>trans</italic>-anethole (<italic>t</italic>A) on antibacterial activity of mupirocin (MUP) against <italic>S. aureus</italic> strains isolated from asymptomatic carriers.</p></sec><sec id="s3"><title>Material and methods</title><p>The content of the FEO was analysed with use of the GC-MS method. The research done on 43 <italic>S. aureus</italic> isolates with different resistance patterns, obtained from nasal vestibule. Antibacterial activity of MUP in combination with FEO or <italic>t</italic>A was examined using the agar dilution method and E-test method. The data analysis was done with the Pearson&#x02019;s &#x003c7;<sup>2</sup> test.</p></sec><sec id="s4"><title>Results</title><p>The chemical composition of FEO was consistent with the European Pharmacopoeia (EP) for the main constituent &#x02013; <italic>t</italic>A (77.9%) according to the EP recommendations. Macrolide-lincosamide-streptogramin B resistance phenotype was prevalent among 39.5% of <italic>S. aureus</italic> isolates. FEO concentrations of 2.0% and 2.5% revealed antibacterial activity against 76.7% of isolates, whereas <italic>t</italic>A inhibited <italic>S. aureus</italic> growth at concentrations &#x0003e; 4.0%. The MIC values for MUP combined with FEO as well as for MUP combined with <italic>t</italic>A were &#x0003c; 0.064 &#x000b5;g/ml for 79.1% and 86.0% of <italic>S. aureus</italic> isolates, respectively.</p></sec><sec id="s5"><title>Conclusions</title><p>Our experiment revealed FEO and <italic>t</italic>A influence on MUP effectiveness. The combination of MUP with FEO as well as MUP with <italic>t</italic>A are worth considering to implement in <italic>S. aureus</italic> eradication procedures. These findings will be useful in designing efficient antistaphylococcal agents which can limit the emergence of antibiotic resistance.</p></sec></abstract><kwd-group><kwd><italic>Staphylococcus aureus</italic></kwd><kwd>mupirocin</kwd><kwd>fennel essential oil</kwd><kwd><italic>trans</italic>-anethole</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1"><title>Introduction</title><p>An extensive transmission of <italic>Staphylococcus aureus</italic> between humans is known to be significantly attributed to asymptomatic carriers. The percentage of persistent carriers of <italic>S. aureu</italic>s in anterior nares is reckoned to be about 20%, whereas the transient nasal carriers and non-carriers account for 60% and 20%, respectively. The persistent carrier-state is being more frequently observed among young children than adults; however the incidence of <italic>S. aureus</italic> carriage among listed groups undergoes numerous changes in individuals aged between 10 and 20 [<xref rid="cit0001" ref-type="bibr">1</xref>]. Higher rates of nasal colonization are observed in hospital staff (around 44%), which doubtlessly poses a great risk of <italic>S. aureus</italic> transmission to hospitalized patients [<xref rid="cit0002" ref-type="bibr">2</xref>, <xref rid="cit0003" ref-type="bibr">3</xref>].</p><p>The carriage of <italic>S. aureus</italic> among medical staff represents an outstanding problem because these can transfer multidrug staphylococcal strains to medical students, other medical staff, and, most importantly, to hospitalized patients. It is estimated that the nasal carriage of <italic>S. aureus</italic> among medical staff ranges between 16.8% and 56.1% [<xref rid="cit0001" ref-type="bibr">1</xref>]. Nasal colonization with <italic>S. aureus</italic> is a risk factor for endogenous staphylococcal infection, especially in patients undergoing surgical procedures with simultaneously reduced immunity. Thus, the eradication is needed in carriers to reduce the risk of infection.</p><p>Available guidelines recommend a topical application of mupirocin (MUP) on mucosal membranes of anterior nares to eradicate the <italic>S. aureus</italic> colonization (methicillin-sensitive <italic>S. aureus</italic> &#x02013; MSSA and methicillin-resistant <italic>S. aureus</italic> &#x02013; MRSA). Due to a high incidence of re-colonization in individuals treated with MUP, it is recommended to use the ointment for at least several weeks [<xref rid="cit0004" ref-type="bibr">4</xref>]. The worldwide increase in resistance to MUP among <italic>S. aureus</italic> explains the need to evaluate the susceptibility to MUP of each <italic>S. aureus</italic> isolate as well as the necessity to search for new treatment options such as application of essential oils which express good antimicrobial properties [<xref rid="cit0005" ref-type="bibr">5</xref>].</p><p><italic>Foeniculum vulgare</italic> Mill. (fennel), biennial plant belonging to the <italic>Apiaceae</italic> family has been easily adapted to many geographic regions [<xref rid="cit0006" ref-type="bibr">6</xref>]. Due to its unique taste, aroma and antimicrobial action, fennel is used in food and cosmetic industry [<xref rid="cit0007" ref-type="bibr">7</xref>]. Fennel is also used to treat gastrointestinal and respiratory tracts disorders. It is known to cause intestinal smooth muscles relaxation and to dissolve bronchial secretion, thus to facilitate easier expectoration. Moreover, the fennel seed extract promotes milk supply in breasts of feeding mothers, assuages period pains, increases sex drive and facilitates birth. Available studies reveal that fennel essential oil (FEO) displays antimicrobial, antioxidant, anti-inflammatory, anti-cancer, anti-spasmodic, anti-coagulant, anti-diabetic, cholagogue, diuretic, anti-hypertensive, hepatoprotective and acaricidal properties [<xref rid="cit0008" ref-type="bibr">8</xref>&#x02013;<xref rid="cit0010" ref-type="bibr">10</xref>].</p><p>FEO is composed mostly of <italic>trans</italic>-anethole (<italic>t</italic>A) and fenchone followed by camphene, estragole, limonene, &#x003b1;-pinene, &#x003b2;-pinene, &#x003b2;-myrcene, camfor, 3-carene, &#x003b1;-phellandrene and <italic>cis</italic>-anethole [<xref rid="cit0009" ref-type="bibr">9</xref>].</p><p><italic>t</italic>A (<italic>p</italic>-metoxypropenylobenzene) is an organic compound, a by-product of terpene synthesis. It constitutes the major ingredient of many essential oils &#x02013; anise (<italic>Pimpinella anisum</italic> L.), star anise (<italic>Illicium verum</italic> Hook. f.) and fennel (<italic>F. vulgare</italic> Mill.). <italic>t</italic>A is widely used in food industry, but also in cosmetic and health-care industries [<xref rid="cit0011" ref-type="bibr">11</xref>, <xref rid="cit0012" ref-type="bibr">12</xref>]. Existing evidence proves its antimicrobial, insecticidal, larvicidal and antioxidative properties [<xref rid="cit0007" ref-type="bibr">7</xref>, <xref rid="cit0013" ref-type="bibr">13</xref>].</p></sec><sec id="sec2"><title>Aim</title><p>The aim of the study was to evaluate the influence of FEO and <italic>t</italic>A on antibacterial activity of MUP against <italic>S. aureus</italic> strains isolated from asymptomatic carriers.</p></sec><sec sec-type="material|methods" id="sec3"><title>Material and methods</title><sec id="sec3.1"><title>Strains and their susceptibility to antimicrobial agents</title><p><italic>Staphylococcus aureus</italic> strains were isolated from medical faculties' students during the 2-years study, in the years 2014&#x02013;2015 at Department of Microbiology, Immunology and Laboratory Medicine of Pomeranian Medical University in Szczecin, Poland. During the study period, 43 bacterial strains from anterior nares swabs have been collected and routinely all were identified with <italic>S. aureus</italic> screening assay. The specimens were cultivated on Columbia agar with 5% sheep blood (bioM&#x000e9;rieux, Poland), identified by colony morphology, tube coagulase test (Biomed, Poland), Staph-Kit test (bioM&#x000e9;rieux, Poland) and biochemical test GP Vitek 2 Compact (bioM&#x000e9;rieux, Poland). <italic>S. aureus</italic> ATCC<sup>&#x000ae;</sup> 29213&#x02122; strain was used to determine the optimal concentration of FEO and <italic>t</italic>A in combination with increasing (E-test method) concentrations of MUP (bioM&#x000e9;rieux, Poland).</p><p>The susceptibility to ciprofloxacin, co-trimoxazole and MUP of <italic>S. aureus</italic> isolates was assessed <italic>via</italic> disc diffusion method and interpreted according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) recommendations. MRSA phenotype was determined using cefoxitin. The presence of macrolide-lincosamide-streptogramin B (MLS<sub>B</sub>) resistance phenotype was determined using erythromycin and clindamycin in accordance with Clinical and Laboratory Standards Institute (CLSI) recommendations [<xref rid="cit0014" ref-type="bibr">14</xref>&#x02013;<xref rid="cit0017" ref-type="bibr">17</xref>]. Antibiotic discs were provided by Diag-Med, Poland.</p></sec><sec id="sec3.2"><title>FEO and <italic>t</italic>A origin</title><p>FEO purchased from Pollena-Aroma (Poland) was used in this study. The essential oil was analysed by gas chromatography-mass spectrometry (GC-MS) at the Faculty of Chemical Technology and Engineering, West Pomeranian University of Technology in Szczecin. The main constituent of tested essential oil was <italic>t</italic>A (77.9%) followed by fenchone (12.8%), &#x003b1;-pinene (3.8%), estragole (2.3%), limonene (2.1%) [<xref rid="cit0014" ref-type="bibr">14</xref>].</p><p><italic>t</italic>A with a purity of not less than 99.0% was obtained from Sigma-Aldrich, Germany.</p></sec><sec id="sec3.3"><title>Susceptibility of <italic>S. aureus</italic> to FEO and <italic>t</italic>A</title><p>The agar dilution method mirrored the one approved by CLSI [<xref rid="cit0018" ref-type="bibr">18</xref>] with the following modification: a final concentration of 1.0% (v/v) Tween<sup>&#x000ae;</sup> 80 (Sigma-Aldrich, Germany) was incorporated into Mueller-Hinton Agar (MHA) (Sigma-Aldrich, Germany) after autoclaving in order to enhance FEO and <italic>t</italic>A solubility. FEO and <italic>t</italic>A at various concentrations (0.1%, 0.25%, 0.5%, 0.75%, 1.0%, 1.5%, 2.0%, 2.5%, 3.0%, 3.5%, 4.0%) (v/v) were independently transferred into MHA with 1.0% (v/v) Tween<sup>&#x000ae;</sup> 80. Plates were dried at 37&#x000b0;C for 30 min prior to inoculation of each them with suspension containing approximately 10<sup>4</sup> CFU/ml of particular <italic>S. aureus</italic> isolates, using a multichannel pipette. MHA with 1.0% (v/v) Tween<sup>&#x000ae;</sup> 80 without FEO or <italic>t</italic>A was used as a positive growth control for <italic>S. aureus</italic>. Minimal inhibitory concentration (MIC) of each tested ingredient was determined after 18 h incubation and recognized as the lowest concentration of oil which completely inhibited the visible growth of <italic>S. aureus</italic> on MHA plate. According to CLSI recommendations, a single colony or a faint haze caused by the inoculum was disregarded [<xref rid="cit0018" ref-type="bibr">18</xref>].</p></sec><sec id="sec3.4"><title>Determination of the optimal concentration of FEO and <italic>t</italic>A in combination with MUP</title><p>Determination of the optimal FEO and <italic>t</italic>A concentration enhancing antibacterial activity of MUP was assessed using ATCC<sup>&#x000ae;</sup> 29213&#x02122; strain of <italic>S. aureus</italic>. The optimization was performed using the agar dilution method and E-test method. For screening of the optimal concentrations of FEO and <italic>t</italic>A enhancing antibacterial activity of MUP, various concentrations (0.1%, 0.25%, 0.5%, 0.75%, 1.0%, 1.5%, 2.0%, 2.5%, 3.0%, 3.5%, 4.0%) (v/v) of these chemicals were distributed into MHA with 1.0% (v/v) Tween<sup>&#x000ae;</sup> 80. Plates were dried for 30 min at 37&#x000b0;C prior to inoculation with sterile cotton swab containing approximately 10<sup>8</sup> CFU/ml of microorganism. Then, the activity of the antibiotic was studied by applying a plastic test strip (E-test) which consisted a predefined, continuous and exponential gradient of MUP on the surface of MHA plates (with and without chemicals &#x02013; control). The plates were incubated for 18 h at 37&#x000b0;C in aerobic conditions. After incubation, the MIC of MUP were calculated. Each test was performed with two replicates.</p></sec><sec id="sec3.5"><title>Antibacterial activity of MUP in combination with FEO or tA</title><p>Antibacterial activity of MUP in combination with FEO or <italic>t</italic>A was examined using the agar dilution method and E-test method in comparison with optimal concentrations revealed by optimization assay. For the screening of antibacterial activity of MUP combined with chemicals, the optimal concentration (v/v) of the chemicals was distributed in MHA with 1.0% (v/v) Tween<sup>&#x000ae;</sup> 80. Plates were dried for 30 min at 37&#x000b0;C prior to inoculation with 10<sup>8</sup> CFU/ml of bacterial suspension. The activity of the antibiotic was studied by applying a plastic test strip (E-test) with a continuous and exponential gradient of MUP on the surface of MHA plates (with and without chemicals &#x02013; control). The plates were incubated for 18 h at 37&#x000b0;C in aerobic conditions. The MIC values were calculated.</p></sec><sec id="sec3.6"><title>Ethical statement</title><p>The study was approved (KB-0012/04/01/14) by the Ethics Committee of the Pomeranian Medical University of Szczecin, Poland.</p></sec><sec id="sec3.7"><title>Statistical analysis</title><p>Comparison of the study data was done using the Pearson&#x02019;s &#x003c7;<sup>2</sup> test. Statistical analyses were performed using the Statistica programme version 12.5. A <italic>p-</italic>value &#x0003c; 0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="sec4"><title>Results</title><sec id="sec4.1"><title>Screening of bacterial susceptibility to antibiotics</title><p>All <italic>S. aureus</italic> strains isolated from the asymptomatic carriers, when tested by disc diffusion method, were susceptible to MUP and to cefoxitin (confirmed MSSA phenotype), whereas one of them showed resistance to ciprofloxacin and another one to co-trimoxazole. The resistance to erythromycin and clindamycin was observed in 39.5% of the isolates. The presence of inducible MLS<sub>B</sub> and constitutive MLS<sub>B</sub> resistance phenotypes was indicated in 34.9% and 4.7% of the strains, respectively. None of the isolates had MS<sub>B</sub> resistance phenotype. <italic>S. aureus</italic> ATCC<sup>&#x000ae;</sup> 29213&#x02122; was susceptible to all antibiotics.</p></sec><sec id="sec4.2"><title>Determination of MICs of FEO and <italic>t</italic>A</title><p>Our investigation showed that FEO in concentrations of 2.0% and 2.5%, represented an inhibiting activity against 76.7% (<italic>p</italic> &#x0003c; 0.0001) of <italic>S. aureus</italic> isolates. <italic>t</italic>A had much weaker inhibitory activity against staphylococci. An equal number of tested isolates (74.4%) were susceptible to <italic>t</italic>A at a concentration higher than 4.0% (<italic>p</italic> &#x0003c; 0.0001) (<xref rid="t0001" ref-type="table">Table 1</xref>). The minimal concentrations of FEO and <italic>t</italic>A inhibiting growth of <italic>S. aureus</italic> ATCC<sup>&#x000ae;</sup> 29213&#x02122; cells were 2.0% and &#x0003e; 4.0%, respectively. It was also observed that the addition of 1% Tween<sup>&#x000ae;</sup> 80 has no impact on growth inhibition of reference strain and isolates.</p><table-wrap id="t0001" position="float"><label>Table 1</label><caption><p>Minimum inhibitory concentration (MIC) of fennel essential oil (FEO), <italic>trans</italic>-anethole (<italic>t</italic>A) and mupirocin (MUP) for <italic>S. aureus</italic> strains isolated from the asymptomatic carriers</p></caption><table frame="hsides" rules="rows"><thead><tr><th valign="top" align="center" rowspan="1" colspan="1">Strain number</th><th valign="top" align="center" rowspan="1" colspan="1">Resistance phenotype</th><th valign="top" align="center" rowspan="1" colspan="1">MIC of FEO<xref ref-type="table-fn" rid="tf1-1">*</xref> (%)</th><th valign="top" align="center" rowspan="1" colspan="1">MIC of <italic>t</italic>A<xref ref-type="table-fn" rid="tf1-1">*</xref> (%)</th><th valign="top" align="center" rowspan="1" colspan="1">MIC of MUP [&#x003bc;g/ml]</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">3.0</td><td align="center" rowspan="1" colspan="1">0.25</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">iMLS<sup>B</sup></td><td align="center" rowspan="1" colspan="1">2.5</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">iMLS<sup>B</sup></td><td align="center" rowspan="1" colspan="1">2.5</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.38</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">iMLS<sup>B</sup></td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">iMLS<sup>B</sup></td><td align="center" rowspan="1" colspan="1">2.5</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.38</td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">iMLS<sup>B</sup></td><td align="center" rowspan="1" colspan="1">2.5</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.125</td></tr><tr><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">iMLS<sup>B</sup></td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.125</td></tr><tr><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">iMLS<sup>B</sup></td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.125</td></tr><tr><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">2.5</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.25</td></tr><tr><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">2.5</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.125</td></tr><tr><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">iMLS<sup>B</sup></td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">4.0</td><td align="center" rowspan="1" colspan="1">0.125</td></tr><tr><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">iMLS<sup>B</sup></td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.25</td></tr><tr><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">2.5</td><td align="center" rowspan="1" colspan="1">4.0</td><td align="center" rowspan="1" colspan="1">0.25</td></tr><tr><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">2.5</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">4.0</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.25</td></tr><tr><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">2.5</td><td align="center" rowspan="1" colspan="1">&#x0003e;4.0</td><td align="center" rowspan="1" colspan="1">0.094</td></tr><tr><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.125</td></tr><tr><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">2.5</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.125</td></tr><tr><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.125</td></tr><tr><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">iMLS<sup>B</sup></td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.125</td></tr><tr><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.094</td></tr><tr><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">2.5</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">2.5</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.25</td></tr><tr><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">2.5</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.25</td></tr><tr><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.125</td></tr><tr><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">iMLS<sup>B</sup></td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.125</td></tr><tr><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">cMLS<sup>B</sup></td><td align="center" rowspan="1" colspan="1">2.5</td><td align="center" rowspan="1" colspan="1">3.5</td><td align="center" rowspan="1" colspan="1">0.125</td></tr><tr><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">iMLS<sup>B</sup></td><td align="center" rowspan="1" colspan="1">2.5</td><td align="center" rowspan="1" colspan="1">3.5</td><td align="center" rowspan="1" colspan="1">0.25</td></tr><tr><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">3.5</td><td align="center" rowspan="1" colspan="1">0.125</td></tr><tr><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">iMLS<sup>B</sup></td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">3.5</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">3.5</td><td align="center" rowspan="1" colspan="1">0.125</td></tr><tr><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">iMLS<sup>B</sup></td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.125</td></tr><tr><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">iMLS<sup>B</sup></td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">3.0</td><td align="center" rowspan="1" colspan="1">0.125</td></tr><tr><td align="center" rowspan="1" colspan="1">41</td><td align="center" rowspan="1" colspan="1">iMLS<sup>B</sup></td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">3.5</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="center" rowspan="1" colspan="1">42</td><td align="center" rowspan="1" colspan="1">cMLS<sup>B</sup></td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.094</td></tr><tr><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">iMLS<sup>B</sup></td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4.0</td><td align="center" rowspan="1" colspan="1">0.125</td></tr></tbody></table><table-wrap-foot><fn id="tf1-1"><label>*</label><p>p &#x0003c; 0.0001.</p></fn><fn><p>iMLS<sub>B</sub> &#x02013; inducible macrolide-lincosamide-streptogramin B resistance phenotype, cMLS<sub>B</sub> &#x02013; constitutive macrolide-lincosamide-streptogramin B resistance phenotype.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec4.3"><title>Optimization of FEO and <italic>t</italic>A concentrations against <italic>S. aureus</italic> ATCC<sup>&#x000ae;</sup> 29213&#x02122;</title><p>The optimal concentrations of FEO or <italic>t</italic>A, enhancing the activity of MUP against reference <italic>S. aureus</italic> strain were 0.75% for FEO and 1.5% for <italic>t</italic>A. It was observed that the addition of FEO and <italic>t</italic>A to MHA with 1% Tween<sup>&#x000ae;</sup> 80 decreased the MIC of MUP from 0.25 &#x000b5;g/ml to &#x02264; 0.064 &#x000b5;g/ml (<xref ref-type="fig" rid="f0001">Figure 1</xref>). The minimal concentration of MUP combined with 0.75% FEO and 1.5% <italic>t</italic>A (which has been recognized to inhibit the growth of reference strain), was lower than 0.064 &#x000b5;g/ml (<xref ref-type="fig" rid="f0002">Figure 2</xref>). It was also noted that the addition of 1% Tween<sup>&#x000ae;</sup> 80 had no impact on the MIC value of MUP alone.</p><fig id="f0001" position="float"><label>Figure 1</label><caption><p>Determination of the optimal concentration of fennel essential oil (FEO) and <italic>trans</italic>-anethole (<italic>t</italic>A) affecting the minimum inhibitory concentration (MIC) of mupirocin (MUP) against <italic>S. aureus</italic> ATCC<sup>&#x000ae;</sup> 29213&#x02122;. Concentration lower than 0.064 &#x003bc;g/ml (*), Mueller-Hinton Agar (MHA)</p></caption><graphic xlink:href="PDIA-36-76425-g001"/></fig><fig id="f0002" position="float"><label>Figure 2</label><caption><p>Minimum inhibitory concentration of mupirocin against <italic>S. aureus</italic> ATCC<sup>&#x000ae;</sup> 29213&#x02122;: <bold>A</bold> &#x02013; Mueller-Hinton Agar (MHA) supplemented with 1% (v/v) Tween<sup>&#x000ae;</sup> 80 without fennel essential oil (FEO) or <italic>trans</italic>-anethole (<italic>t</italic>A), <bold>B</bold> &#x02013; MHA supplemented with 1% (v/v) Tween<sup>&#x000ae;</sup> 80 and 0.75% FEO, <bold>C</bold> &#x02013; MHA supplemented with 1% (v/v) Tween<sup>&#x000ae;</sup> 80 and 1.5% <italic>t</italic>A</p></caption><graphic xlink:href="PDIA-36-76425-g002"/></fig></sec><sec id="sec4.4"><title>Influence of FEO or <italic>t</italic>A on antibacterial activity of MUP</title><p>A significant increase in antistaphylococcal activity of MUP combined with FEO or <italic>t</italic>A was confirmed by the agar dilution method and E-test method. The influence of FEO or <italic>t</italic>A used in combination with MUP was comparable. MICs of MUP combined with FEO and MUP combined with <italic>t</italic>A were &#x0003c; 0.064 &#x000b5;g/ml for 79.1% (<italic>p</italic> &#x0003c; 0.0001) and 86.0% (<italic>p</italic> &#x0003c; 0.0001) of <italic>S. aureus</italic> isolates, respectively. However, MICs of MUP without FEO or <italic>t</italic>A were 0.19&#x02013;0.125 &#x000b5;g/ml for 69.8% of <italic>S. aureus</italic> strains. The addition of FEO or <italic>t</italic>A to MHA reduced MIC values from 0.17 &#x000b1;0.07 &#x000b5;g/ml to 0.064 &#x000b5;g/ml (<italic>p</italic> &#x0003c; 0.0001), but the largest number of isolates (34 and 37 strains of <italic>S. aureus</italic>, respectively for FEO and <italic>t</italic>A) were inhibited by a concentration lower than 0.064 &#x000b5;g/ml (<italic>p</italic> &#x0003c; 0.0001). No correlation was found between resistance phenotypes and susceptibility towards MUP with FEO or <italic>t</italic>A combinations (<xref rid="t0001" ref-type="table">Table 1</xref>).</p></sec></sec><sec sec-type="discussion" id="sec5"><title>Discussion</title><p>The anethole-dominated FEO represents one of the two reference FEO chemotypes accepted by Pharmacopoeia for medical application [<xref rid="cit0019" ref-type="bibr">19</xref>]. The content of <italic>t</italic>A in FEO ranges from 38.8% (Albania, Yugoslavia) to 84.1% (Turkey, Albania) and is dependent on its geographical origin. The content of <italic>t</italic>A in our tested FEO was close to French and Argentinean fennel oil; those contain 75.5% and 79.9% of <italic>t</italic>A, respectively [<xref rid="cit0020" ref-type="bibr">20</xref>]. The European Pharmacopoeia (EP) requires minimum 60% of <italic>t</italic>A in bitter FEO composition. The remaining needed components are as follows: 15% of fenchone, 1&#x02013;10% of &#x003b1;-pinene; not more than 6% of estragole and 1&#x02013;5% of limonene. The chemical composition of the tested FEO was consistent with EP requirements regarding <italic>t</italic>A, &#x003b1;-pinene, estragole and limonene. The content of fenchone was slightly lower when compared with reference data.</p><p>According to the available data, the increase in resistance among <italic>S. aureus</italic> to macrolide, lincosamide and streptogramin B antibiotics is being observed [<xref rid="cit0021" ref-type="bibr">21</xref>]. The presence of MLS<sub>B</sub> resistance mechanism among staphylococci excludes treatment with the above-mentioned antibiotics, while it is known that erythromycin and clindamycin are commonly used in empirical treatment of Gram-positive bacteria infections. Clindamycin is an alternative therapeutic option for the treatment of staphylococcal skin and soft tissue infections, but also an alternative for patients with penicillin allergies [<xref rid="cit0022" ref-type="bibr">22</xref>]. The degree of resistance to macrolides among MRSA is still increasing, as well in MSSA, and this constitutes a significant challenge for clinicians dealing with skin infections [<xref rid="cit0023" ref-type="bibr">23</xref>, <xref rid="cit0024" ref-type="bibr">24</xref>]. According to the study of Yilmaz <italic>et al</italic>., the inducible MLS<sub>B</sub> resistance phenotype was detected in 14.8% of MSSA isolates [<xref rid="cit0025" ref-type="bibr">25</xref>]. Similar results were obtained by Prabhu <italic>et al</italic>., who reported that constitutive and inducible MLS<sub>B</sub> resistance phenotype among MSSA occurred in 18% of isolates from different clinical samples [<xref rid="cit0022" ref-type="bibr">22</xref>]. Our results indicate that medical staff is a significant factor in the spread of pathogens resistant to macrolide, lincosamide and streptogramin B antibiotics. Therefore, there is a need for continuous monitoring of this type of bacterial resistance and implementation of new methods to prevent the spread of resistance.</p><p>In our previous study we obtained promising results and indicated that FEO was the most effective in combination with MUP [<xref rid="cit0014" ref-type="bibr">14</xref>]. Using the disc diffusion method, the increasing zone of growth inhibition of <italic>S. aureus</italic> was found. We further decided to design an exact research using the agar dilution method and E-test method against higher number of isolates from nasal vestibule with different patterns of resistance. We studied not only the combination of FEO with MUP, but also the combination of FEO main component &#x02013; <italic>t</italic>A with MUP which, according to available data, improves cutaneous wound healing. This provides data on its oral LD<sub>50</sub> values between 1.8&#x02013;5.0 g for mice, rats and guinea pigs [<xref rid="cit0026" ref-type="bibr">26</xref>, <xref rid="cit0027" ref-type="bibr">27</xref>]. It can be concluded that antimicrobial activity of FEO compared with <italic>t</italic>A is determined by more than one particular component, and depends on the synergistic activities of different oil constituents. This is even despite <italic>t</italic>A high content. The MIC values of FEO were much lower than MICs of <italic>t</italic>A, ranging from 1.5 to 2.5% and from 3.0 to &#x0003e; 4.0%, respectively. Summarizing, better results were obtained when combined FEO with MUP. The similar results were presented by Kazemi <italic>et al</italic>. in the study on antistaphylococcal activity of FEO containing mainly <italic>t</italic>A, thymol, &#x003b1;-pinene, 1,8-cineole and fenchone [<xref rid="cit0028" ref-type="bibr">28</xref>]. They found that analysed FEO was more effective against human pathogenic <italic>S. aureus</italic> with MIC &#x02013; 0.5 &#x000b5;g/ml than the main constituent &#x02013; <italic>t</italic>A itself (MIC &#x02013; 4.0 &#x000b5;g/ml). Only pure thymol presented comparable activity to phenolic compounds of this oil. Lachowicz <italic>et al</italic>. showed the lesser antimicrobial activity of artificially prepared main constituent mixture (linalool-estragole) compared with anise oil [<xref rid="cit0029" ref-type="bibr">29</xref>]. These results indicated that other less predominant components in anise oil most likely contribute to its antimicrobial activity.</p><p>Many scientific centres are investigating effective combinations of chemical agents as well as compounds of natural origin on decrease the resistance of microorganisms. Itaqui <italic>et al</italic>. investigated the interactions between azithromycin and terbinafine in combination with MUP in order to reduce the therapeutic doses of systemic and local treatment against <italic>Pythium insidiosum</italic> responsible for ocular, cutaneous/subcutaneous, vascular and disseminated pythiosis [<xref rid="cit0030" ref-type="bibr">30</xref>]. Sato <italic>et al</italic>. found a synergistic effect of MUP and isoflavanone (Bidwillon B) obtained from <italic>Erythrina variegata</italic> against MRSA [<xref rid="cit0031" ref-type="bibr">31</xref>]. The results showed that Bidwillon B appears to be not only a strong antistaphylococcal agent itself, but also combined with MUP, and thus can be helpful in the elimination of nasal and skin MRSA carriage. According to the findings of Kifer <italic>et al</italic>., some combinations of MUP and monoterpenes such as menthol, thymol, 1,8-cineole could be applied in the therapy of infections caused by <italic>S. aureus,</italic> including chronic rhinosinusitis [<xref rid="cit0032" ref-type="bibr">32</xref>]. In this case, the treatment is based on bacterial biofilm growth prevention. Because of the common use of MUP for staphylococci eradication in patients and medical staff, there is a risk of a significant resistance rate increase in the future. The new active compounds acting additively or synergistically with MUP can be effective in prevention of the resistance to this antibiotic.</p></sec><sec sec-type="conclusions" id="sec6"><title>Conclusions</title><p>Our investigation showed that FEO or <italic>t</italic>A could be added to mupirocin-based agents to eradicate the nasal carriage of <italic>S. aureus</italic> and/or to limit the emergence of mupirocin resistance as well. The FEO or <italic>t</italic>A combined with MUP tested in the study was effective against MLSB resistant <italic>S. aureus</italic> isolates and such combination/s may be helpful in nasal eradication of staphylococci with some patterns of resistance. This is not excluded, that in the coming future the FEO or <italic>t</italic>A will be components of agents to mucous membranes antisepsis, but more research in this field are required.</p></sec></body><back><ack><title>Acknowledgments</title><p>We thank the Pomeranian Medical University in Szczecin for their financial support.</p></ack><sec sec-type="COI-statement"><title>Conflict of interest</title><p>The authors declare no conflict of interest.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rongpharpi</surname><given-names>SR</given-names></name><name><surname>Hazarika</surname><given-names>NK</given-names></name><name><surname>Kalita</surname><given-names>H</given-names></name></person-group><article-title>The prevalence of nasal carriage of <italic>Staphylococcus aureus</italic> among healthcare workers at tertiary care hospital in assam with special reference of MRSA</article-title><source>J Clin Diagn Res</source><year>2013</year><volume>7</volume><fpage>257</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">23543837</pub-id></element-citation></ref><ref id="cit0002"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boncompain</surname><given-names>CA</given-names></name><name><surname>Su&#x000e1;rez</surname><given-names>CA</given-names></name><name><surname>Morbidoni</surname><given-names>HR</given-names></name></person-group><article-title><italic>Staphylococcus aureus</italic> nasal carriage in health care workers: first report from a major public hospital in Argentina</article-title><source>Rev Argent Microbiol</source><year>2017</year><volume>49</volume><fpage>125</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">28343857</pub-id></element-citation></ref><ref id="cit0003"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khanal</surname><given-names>R</given-names></name><name><surname>Sah</surname><given-names>P</given-names></name><name><surname>Lamichhane</surname><given-names>P</given-names></name><etal/></person-group><article-title>Nasal carriage of methicillin resistant <italic>Staphylococcus aureus</italic> among health care workers at a tertiary care hospital in Western Nepal</article-title><source>Antimicrob Resist Infect Control</source><year>2015</year><volume>4</volume><fpage>39</fpage><pub-id pub-id-type="pmid">26457182</pub-id></element-citation></ref><ref id="cit0004"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coates</surname><given-names>T</given-names></name><name><surname>Bax</surname><given-names>R</given-names></name><name><surname>Coates</surname><given-names>A</given-names></name></person-group><article-title>Nasal decolonization of <italic>Staphylococcus aureus</italic> with mupirocin: strengths, weaknesses and future prospects</article-title><source>J Antimicrob Chemother</source><year>2009</year><volume>64</volume><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">19451132</pub-id></element-citation></ref><ref id="cit0005"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudresh</surname><given-names>MS</given-names></name><name><surname>Ravi</surname><given-names>GS</given-names></name><name><surname>Motagi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Prevalence of mupirocin resistance among staphylococci, its clinical significance and relationship to clinical use</article-title><source>J Lab Physicians</source><year>2015</year><volume>7</volume><fpage>103</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">26417160</pub-id></element-citation></ref><ref id="cit0006"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esquivel-Ferri&#x000f1;o</surname><given-names>PC</given-names></name><name><surname>Favela-Hern&#x000e1;ndez</surname><given-names>JM</given-names></name><name><surname>Garza-Gonz&#x000e1;lez</surname><given-names>E</given-names></name><etal/></person-group><article-title>Antimycobacterial activity of constituents from <italic>Foeniculum vulgare</italic> var. <italic>dulce</italic> grown in Mexico</article-title><source>Molecules</source><year>2012</year><volume>17</volume><fpage>8471</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">22797778</pub-id></element-citation></ref><ref id="cit0007"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahat</surname><given-names>AA</given-names></name><name><surname>Ibrahim</surname><given-names>AY</given-names></name><name><surname>Hendawy</surname><given-names>SF</given-names></name><etal/></person-group><article-title>Chemical composition, antimicrobial and antioxidant activities of essential oils from organically cultivated fennel cultivars</article-title><source>Molecules</source><year>2011</year><volume>16</volume><fpage>1366</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">21285921</pub-id></element-citation></ref><ref id="cit0008"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostad</surname><given-names>SN</given-names></name><name><surname>Soodi</surname><given-names>M</given-names></name><name><surname>Shariffzadeh</surname><given-names>M</given-names></name><etal/></person-group><article-title>The effect of fennel essential oil on uterine contraction as a model for dysmenorrhea, pharmacology and toxicology study</article-title><source>J Ethnopharmacol</source><year>2001</year><volume>76</volume><fpage>299</fpage><lpage>304</lpage><pub-id pub-id-type="pmid">11448553</pub-id></element-citation></ref><ref id="cit0009"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozbek</surname><given-names>H</given-names></name><name><surname>U&#x0011f;ra&#x0015f;</surname><given-names>S</given-names></name><name><surname>D&#x000fc;lger</surname><given-names>H</given-names></name><etal/></person-group><article-title>Hepatoprotective effect of <italic>Foeniculum vulgare</italic> essential oil</article-title><source>Fitoterapia</source><year>2003</year><volume>74</volume><fpage>317</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12727504</pub-id></element-citation></ref><ref id="cit0010"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diao</surname><given-names>W</given-names></name><name><surname>Hu</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Chemical composition, antibacterial activity and mechanism of action of essential oil from seeds of fennel (<italic>Foeniculum vulgare</italic> Mill.)</article-title><source>Food Control</source><year>2014</year><volume>35</volume><fpage>109</fpage><lpage>16</lpage></element-citation></ref><ref id="cit0011"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimoni</surname><given-names>E</given-names></name><name><surname>Baasov</surname><given-names>T</given-names></name><name><surname>Ravid</surname><given-names>U</given-names></name><etal/></person-group><article-title>The <italic>trans</italic>-anethole degradation pathway in an <italic>Arthrobacter</italic> sp</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>11866</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">11805095</pub-id></element-citation></ref><ref id="cit0012"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>J</given-names></name><name><surname>Seo</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Identification of syn- and anti-anethole-2,3-epoxides in the metabolism of trans-anethole by the newly isolated bacterium <italic>Pseudomonas putida</italic> JYR-1</article-title><source>J Agric Food Chem</source><year>2005</year><volume>53</volume><fpage>5954</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16028980</pub-id></element-citation></ref><ref id="cit0013"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><etal/></person-group><article-title>Antifungal activity of the essential oil of <italic>Illicium verum</italic> fruit and its main component <italic>trans</italic>-anethole</article-title><source>Molecules</source><year>2010</year><volume>15</volume><fpage>7558</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">21030909</pub-id></element-citation></ref><ref id="cit0014"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwiatkowski</surname><given-names>P</given-names></name><name><surname>Mnichowska-Polanowska</surname><given-names>M</given-names></name><name><surname>Pruss</surname><given-names>A</given-names></name><etal/></person-group><article-title>The effect of fennel essentials oil in combination with antibiotics on <italic>Staphylococcus aureus</italic> strains isolated from carriers</article-title><source>Burns</source><year>2017</year><volume>43</volume><fpage>1544</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">28917968</pub-id></element-citation></ref><ref id="cit0015"><label>15</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>European Committee on Antimicrobial Susceptibility Testing (EUCAST)</collab></person-group><source>Breakpoints tables for interpretation of MICs and zones diameters. Version 5.0</source><year>2015</year><comment><ext-link ext-link-type="uri" xlink:href="http://www.eucast.org">http://www.eucast.org</ext-link></comment></element-citation></ref><ref id="cit0016"><label>16</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Clinical and Laboratory Standards Institute (CLSI)</collab></person-group><source>Performance standards for antimicrobial susceptibility testing</source><year>2008</year><publisher-loc>Wayne, PA</publisher-loc><comment>Document M100-S18</comment></element-citation></ref><ref id="cit0017"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saderi</surname><given-names>H</given-names></name><name><surname>Emadi</surname><given-names>B</given-names></name><name><surname>Owlia</surname><given-names>P</given-names></name></person-group><article-title>Phenotypic and genotypic study of macrolide, lincosamide and streptogramin B (MLS<sub>B</sub>) resistance in clinical isolates of <italic>Staphylococcus aureus</italic> in Teheran, Iran</article-title><source>Med Sci Monit</source><year>2011</year><volume>17</volume><fpage>48</fpage><lpage>53</lpage></element-citation></ref><ref id="cit0018"><label>18</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Clinical and Laboratory Standards Institute (CLSI)</collab></person-group><source>Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically; approved standard &#x02013; eight edition</source><year>2009</year><publisher-loc>Wayne, Pa</publisher-loc><comment>Document M07-A7</comment></element-citation></ref><ref id="cit0019"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kr&#x000fc;ger</surname><given-names>H</given-names></name><name><surname>Hammer</surname><given-names>K</given-names></name></person-group><article-title>Chemotypes of fennel (<italic>Foeniculum vulgare</italic> Mill.)</article-title><source>J Essent Oil Res</source><year>1999</year><volume>11</volume><fpage>79</fpage><lpage>82</lpage></element-citation></ref><ref id="cit0020"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badoc</surname><given-names>A</given-names></name><name><surname>Deffieux</surname><given-names>G</given-names></name><name><surname>Lamarti</surname><given-names>A</given-names></name><etal/></person-group><article-title>Essential oil of <italic>Foeniculum vulgare</italic> Mill. (Fennel) subsp. piperitum (Ucria) Cout. fruit</article-title><source>J Essent Oil Res</source><year>1994</year><volume>6</volume><fpage>333</fpage><lpage>6</lpage></element-citation></ref><ref id="cit0021"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adaleti</surname><given-names>R</given-names></name><name><surname>Nakipoglu</surname><given-names>Y</given-names></name><name><surname>Ceran</surname><given-names>N</given-names></name><etal/></person-group><article-title>Prevalence of phenotypic resistance of <italic>Staphylococcus aureus</italic> isolates to macrolide, lincosamide, streptogramin B, ketolid and linezolid antibiotics in Turkey</article-title><source>Braz J Infect Dis</source><year>2010</year><volume>14</volume><fpage>11</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">20428647</pub-id></element-citation></ref><ref id="cit0022"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prabhu</surname><given-names>K</given-names></name><name><surname>Rao</surname><given-names>S</given-names></name><name><surname>Rao</surname><given-names>V</given-names></name></person-group><article-title>Inducible clindamycin resistance <italic>Staphylococcus aureus</italic> isolated from clinical samples</article-title><source>J Lab Physicians</source><year>2011</year><volume>3</volume><fpage>25</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">21701659</pub-id></element-citation></ref><ref id="cit0023"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aydeniz</surname><given-names>OF</given-names></name><name><surname>Cevahir</surname><given-names>N</given-names></name><name><surname>Kaleli</surname><given-names>I</given-names></name></person-group><article-title>Investigation of macrolide, lincosamide and streptogramin B resistance in <italic>Staphylococcus aureus</italic> strains isolated from clinical samples by phenotypical and genotypical methods</article-title><source>Mikrobyol Bul</source><year>2015</year><volume>49</volume><fpage>1</fpage><lpage>14</lpage></element-citation></ref><ref id="cit0024"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikam</surname><given-names>AP</given-names></name><name><surname>Bhise</surname><given-names>PR</given-names></name><name><surname>Deshmukh</surname><given-names>MM</given-names></name></person-group><article-title>Phenotypic detection of inducible clindamycin resistance among <italic>Staphylococcus aureus</italic> isolates</article-title><source>Int J Res Med Sci</source><year>2017</year><volume>5</volume><fpage>543</fpage><lpage>7</lpage></element-citation></ref><ref id="cit0025"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yilmaz</surname><given-names>G</given-names></name><name><surname>Aydin</surname><given-names>K</given-names></name><name><surname>Iskender</surname><given-names>S</given-names></name><etal/></person-group><article-title>Detection and prevalence of inducible clindamycin resistance in staphylococci</article-title><source>J Med Microbiol</source><year>2007</year><volume>56</volume><fpage>342</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17314364</pub-id></element-citation></ref><ref id="cit0026"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavalcanti</surname><given-names>JM</given-names></name><name><surname>Leal-Cardoso</surname><given-names>JH</given-names></name><name><surname>Diniz</surname><given-names>LR</given-names></name><etal/></person-group><article-title>The essential oil of <italic>Croton zehntneri</italic> and <italic>trans</italic>-anethole improves cutaneous wound healing</article-title><source>J Ethnopharmacol</source><year>2012</year><volume>144</volume><fpage>240</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">23000167</pub-id></element-citation></ref><ref id="cit0027"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marinov</surname><given-names>V</given-names></name><name><surname>Valcheva-Kuzmanova</surname><given-names>S</given-names></name></person-group><article-title>Review on the pharmacological activities of anethole</article-title><source>Scr Sci Pharm</source><year>2015</year><volume>2</volume><fpage>14</fpage><lpage>19</lpage></element-citation></ref><ref id="cit0028"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazemi</surname><given-names>M</given-names></name><name><surname>Mousavi</surname><given-names>E</given-names></name><name><surname>Kharestani</surname><given-names>H</given-names></name></person-group><article-title>Chemical composition and antimicrobial activities of essential oils of <italic>Varthemia persica, Foeniculum vulgare, Ferula lycia</italic></article-title><source>Curr Res Bacteriol</source><year>2012</year><volume>5</volume><fpage>42</fpage><lpage>52</lpage></element-citation></ref><ref id="cit0029"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lachowicz</surname><given-names>KJ</given-names></name><name><surname>Jones</surname><given-names>GP</given-names></name><name><surname>Briggs</surname><given-names>DR</given-names></name><etal/></person-group><article-title>The synergistic preservative effects of the essential oils of sweet basil (<italic>Ocimum basilicum</italic> L.) against acid-tolerant food microflora</article-title><source>Lett Appl Microbiol</source><year>1998</year><volume>26</volume><fpage>209</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">9569711</pub-id></element-citation></ref><ref id="cit0030"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itaqui</surname><given-names>SR</given-names></name><name><surname>Verdi</surname><given-names>CM</given-names></name><name><surname>Tondolo</surname><given-names>JS</given-names></name><etal/></person-group><article-title><italic>In vitro</italic> synergism between azithromycin or terbinafine and topical antimicrobial agents against <italic>Pythium insidiosum</italic></article-title><source>Antimicrob Agents Chemother</source><year>2016</year><volume>60</volume><fpage>5023</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">27216049</pub-id></element-citation></ref><ref id="cit0031"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Yamaguchi</surname><given-names>R</given-names></name><etal/></person-group><article-title>Synergistic effects of mupirocin and an isoflavanone isolated from <italic>Erythrina variegata</italic> on growth and recovery of methicillin-resistant <italic>Staphylococcus aureus</italic>
</article-title><source>Int J Antimicrob Agents</source><year>2004</year><volume>24</volume><fpage>241</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15325427</pub-id></element-citation></ref><ref id="cit0032"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kifer</surname><given-names>D</given-names></name><name><surname>Mu&#x0017e;ini&#x00107;</surname><given-names>V</given-names></name><name><surname>Klari&#x00107;</surname><given-names>M&#x00160;</given-names></name></person-group><article-title>Antimicrobial potency of single and combined mupirocin and monoterpenes, thymol, menthol and 1,8-cineole against <italic>Staphylococcus aureus</italic> planktonic and biofilm growth</article-title><source>J Antibiot (Tokyo)</source><year>2016</year><volume>69</volume><fpage>689</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">26883392</pub-id></element-citation></ref></ref-list></back></article>